To mark Breast Cancer Awareness month, the Focused Ultrasound Foundation partnered with Breast Cancer Alliance (BCA) to host a webinar to explain how emerging immunotherapy research is providing hope to treat breast cancer more effectively.
The Foundation and BCA are funding groundbreaking research to treat breast cancer, and have partnered to share knowledge with the understanding that combination therapies, such as those presented in this webinar, will be the future. The organizations are also committed to advancing health equity and ensuring access to these groundbreaking therapies.
CHAPTERS
00:00 Introduction
03:54 Presentation: David Brenin, MD
28:21 Presentation: Scott Abrams, PhD & Michael Nemeth, PhD
40:32 Q&A
01:00:03 Conclusion
PANELISTS
David Brenin, MD
University of Virginia (UVA Health)
M.C. Wilhelm Professor in Diseases of the Breast
Division Chief of Breast and Melanoma Surgery
Co-Director, UVA Focused Ultrasound Cancer Immunotherapy Center
Scott Abrams, PhD
Roswell Park Comprehensive Cancer Center
Professor of Oncology, Department of Immunology
Co-Leader, Tumor Immunology and Immunotherapy CCSG Program
Michael Nemeth, PhD
Roswell Park Comprehensive Cancer Center
Assistant Professor of Oncology, Department of Immunology
Co-Chair, Leukemia Translational Research Group
MODERATOR
Natasha Sheybani, PhD
University of Virginia
Assistant Professor, Biomedical Engineering
Research Director, UVA Focused Ultrasound Cancer Immunotherapy Center
HOSTS
Suzanne LeBlang, MD
Focused Ultrasound Foundation
Director of Clinical Relations
Yonni Wattenmaker
Breast Cancer Alliance
Executive Director
FUSF RESOURCES
Website:
[ Ссылка ]
Subscribe to the Newsletter:
[ Ссылка ]
Read the latest issue:
[ Ссылка ]
